Knowable
Molecular signatures of aging are changing how conservationists assess population health, resilience and risk.
The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.
When a single working copy of a gene is not enough, diseases called haploinsufficiencies can result. Researchers are figuring out ways to treat them.
Even as scientists celebrate progress in the lab, a stigma-busting movement asserts that those with the autoimmune skin condition are more in need of acceptance than medicine
By taking advantage of differing circadian rhythms in healthy cells and tumors, researchers hope to add a powerful new tool for treating the disease.